Waters - WAT Stock Forecast, Price & News

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" WAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
View WAT analyst ratings or view top-rated stocks.

7 brokers have issued 1 year price targets for Waters' shares. Their WAT share price forecasts range from $317.00 to $380.00. On average, they anticipate the company's stock price to reach $349.67 in the next twelve months. This suggests a possible upside of 5.0% from the stock's current price.
View analysts price targets for WAT or view top-rated stocks among Wall Street analysts.

Waters' stock was trading at $342.58 at the beginning of the year. Since then, WAT stock has decreased by 2.8% and is now trading at $333.13.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our WAT earnings forecast.

Waters will be holding an earnings conference call on Wednesday, February 15th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Waters Co. (NYSE:WAT) released its quarterly earnings data on Tuesday, November, 1st. The medical instruments supplier reported $2.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.07. The medical instruments supplier earned $708.56 million during the quarter, compared to analysts' expectations of $680.30 million. Waters had a net margin of 23.63% and a trailing twelve-month return on equity of 189.79%.

Waters issued an update on its fourth quarter 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share guidance of $3.66-$3.76 for the period, compared to the consensus estimate of $3.85. The company issued revenue guidance of $819.72 million-$836.45 million, compared to the consensus revenue estimate of $838.20 million.

13 employees have rated Waters Chief Executive Officer Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among the company's employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Raytheon Technologies (RTX), CVS Health (CVS), Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters' stock is owned by many different institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.68%), Allspring Global Investments Holdings LLC (0.29%), Schaper Benz & Wise Investment Counsel Inc. WI (0.17%), UMB Bank n.a. (0.12%), Boston Financial Mangement LLC (0.12%) and New York State Teachers Retirement System (0.11%). Insiders that own company stock include Christopher A Kuebler, Christopher J Oconnell, Edward Conard, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Linda Baddour, Michael C Harrington, Michael J Berendt, Robert G Carson, Sherry Buck and Thomas P Salice.
View institutional ownership trends.

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WAT stock can currently be purchased for approximately $333.13.

Waters (NYSE:WAT) has a market capitalization of $19.79 billion and generates $2.79 billion in revenue each year. The medical instruments supplier earns $692.84 million in net income (profit) each year or $11.46 on an earnings per share basis.

The company employs 7,800 workers across the globe.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The official website for the company is www.waters.com. The medical instruments supplier can be reached via phone at (508) 478-2000, via email at investor_relations@waters.com, or via fax at 508-872-1990.